Thomas D Schiano MD

Hepatology & Liver Transplantation, Nutrition

Professor of Medicine, Mount Sinai School of Medicine Medical Director, Liver Transplantation Medical Director, Intestinal Transplantation Director, Clinical Hepatology

Join to View Full Profile

5 E 98th St12th FlNew York, NY 10029
Phone+1 212-241-0034
Fax+1 212-289-7738

Summary

Dr. Thomas Schiano is a gastroenterologist based in New York, NY, with subspecialties in gastroenterology, hepatology, liver transplantation, and nutrition. He completed his education with a medical degree from Universidad del Noreste and various fellowships, including those at Temple University, Memorial Sloan Kettering Cancer Center and Icahn School of Medicine at Mount Sinai. He is Professor of Medicine at the Icahn School of Medicine at Mount Sinai and is Medical Director of Liver Transplantation, Director of Clinical Hepatology and Medical Director of Intestinal Transplantation at the Mount Sinai Medical Center. Dr. Schiano has received recognition as a top doctor by Castle Connolly and holds fellowships from the ACP, AASLD, AFA, ASGE and AST.

Education & Training

Icahn School of Medicine at Mount SinaiFellowship, Transplant Hepatology, 1995 - 1996
Temple University HospitalFellowship, Gastroenterology, 1993 - 1995
Memorial Sloan Kettering Cancer CenterFellowship, Clinical Nutrition, 1992 - 1993
Maimonides Medical CenterChief Residency, Internal Medicine, 1991 - 1992
Maimonides Medical CenterResidency, Internal Medicine, 1988 - 1992
Universidad del NoresteClass of 1987

Certifications & Licensure

NY State Medical License 1989 - 2026
NJ State Medical License 2016 - 2025
IL State Medical License 1996 - 1999
PA State Medical License 1993 - 1996

Awards, Honors, & Recognition

New York Magazine: Top Doctors Castle Connolly, 2009-2014
America's Top Doctors Castle Connolly, 2009-2014
Top Doctors: New York Metro Area Castle Connolly, 2009-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Fellow (FACP) American College of Physicians, 1999
Super Doctor SuperDoctors.com
Join now to see all

Clinical Trials

Prevention of Bleeding in Patient With Cirrhosis Undergoing Dental Extraction Start of enrollment: 2003 Oct 01
Completed
Not Applicable
CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL") Start of enrollment: 2012 Oct 29
Completed
Phase 4
Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection Start of enrollment: 2012 Mar 01
Terminated
Phase 1
Discovery and Validation of Proteogenomic Biomarker Panels in Liver Transplant Recipients Start of enrollment: 2012 Aug 01
Completed
Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. Start of enrollment: 2013 Jun 01
Completed
Phase 3
Assessment of Intrahepatic Hepatitis C Virus (HCV) RNA Levels at the Time of Liver Transplantation Start of enrollment: 2013 Jun 01
Unknown status
CM-101 in PSC Patients -The SPRING Study Start of enrollment: 2020 Oct 01
Active, not recruiting
Phase 2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

Sex-based Differences and Comparative Predictive Value of MELD 3.0 in Simultaneous Liver-Kidney Transplantation Waitlist Outcomes After Standardization of Listing Crit...
Emily A Leven, Ditian Li, Emilia Bagiella, Thomas D Schiano, Lauren Tal Grinspan
Transplantation Direct. 2025-05-01
Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survival.
Vincenzo Ronca, Alessandro Parente, Ellina Lytvyak, Bettina E Hansen, Gideon Hirschfield
JHEP Reports. 2025-05-01
Jehovah's Witnesses: Challenges in liver disease management and in liver transplantation.
Jordan S Sack, Sander S Florman, Thomas D Schiano
Liver Transplantation. 2025-05-01

Abstracts/Posters

Utility of Thrombophilia Testing in Portal Vein Thrombosis in a Large Single Institutional Cohort
Thomas Schiano, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
The Use of Direct Oral Anticoagulants in Non-Cirrhotic Portal Vein Thrombosis
Thomas Schiano, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Press Mentions

Alcohol-Related Health Issues on the Rise in Young AdultsJanuary 16th, 2023
‘Every Day, I’m Grateful’; Young Woman Donates Liver to Twin SisterDecember 24th, 2021
Safety, Efficacy, and Long-Term Outcomes of Anticoagulation in Cirrhotic Portal Vein ThrombosisNovember 5th, 2020
Join now to see all